camptothecin has been researched along with methyl pyruvate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hull, R; Ntwasa, MM | 1 |
| Monchusi, B; Ntwasa, M | 1 |
2 other study(ies) available for camptothecin and methyl pyruvate
| Article | Year |
|---|---|
Glycolytic flux occurs in Drosophila melanogaster recovering from camptothecin treatment.
Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carrier Proteins; Cell Division; Colorectal Neoplasms; Drosophila melanogaster; Drosophila Proteins; Drug-Related Side Effects and Adverse Reactions; Female; Genital Neoplasms, Female; Glycolysis; Humans; Proteomics; Pyruvates; Recovery of Function; Tumor Suppressor Protein p53 | 2010 |
Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Camptothecin; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Gene Expression; Humans; Irinotecan; Protective Agents; Pyruvates | 2017 |